Rosuvastatin Terminated Phase 3 Trials for Stroke Treatment

IndicationsStatusPurposePhase
TerminatedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT01364220The Effects of Very Early Use of Rosuvastatin in Preventing Recurrence of Ischemic Stroke